PCS
GILD icon

Personal CFO Solutions’s Gilead Sciences GILD Stock Holding History

Personal CFO Solutions’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$657K Buy
4,718
+146
+3% +$20.4K 0.09% 202
2025
Q4 		$561K Buy
4,572
+76
+2% +$9.24K 0.09% 216
2025
Q3 		$499K Buy
4,496
+11
+0.2% +$1.25K 0.09% 228
2025
Q2 		$497K Buy
4,485
+386
+9% +$41.1K 0.09% 225
2025
Q1 		$459K Buy
4,099
+1,857
+83% +$192K 0.09% 221
2024
Q4 		$207K Buy
+2,242
New +$202K 0.04% 436
2024
Q2 		– Sell
-3,114
Closed -$228K – 564
2024
Q1 		$228K Buy
3,114
+168
+6% +$12.9K 0.04% 487
2023
Q4 		$239K Sell
2,946
-4,976
-63% -$387K 0.04% 438
2023
Q3 		$594K Sell
7,922
-749
-9% -$57.6K 0.12% 165
2023
Q2 		$668K Sell
8,671
-2,079
-19% -$166K 0.14% 151
2023
Q1 		$892K Sell
10,750
-350
-3% -$29K 0.18% 102
2022
Q4 		$958K Buy
11,100
+4,662
+72% +$369K 0.2% 95
2022
Q3 		$397K Buy
6,438
+238
+4% +$15K 0.1% 194
2022
Q2 		$383K Sell
6,200
-375
-6% -$23.2K 0.09% 206
2022
Q1 		$391K Buy
+6,575
New +$420K 0.08% 246
2021
Q4 		– Sell
-10,624
Closed -$742K – 487
2021
Q3 		$742K Buy
10,624
+773
+8% +$54.3K 0.15% 136
2021
Q2 		$678K Buy
9,851
+1,095
+13% +$73.1K 0.14% 142
2021
Q1 		$566K Buy
8,756
+4
+0% +$258 0.12% 152
2020
Q4 		$510K Sell
8,752
-4,150
-32% -$250K 0.13% 157
2020
Q3 		$1K Sell
12,902
-164
-1% -$11.4K 0.33% 77
2020
Q2 		$1M Sell
13,066
-303
-2% -$23.2K 0.3% 77
2020
Q1 		$999K Buy
13,369
+1,506
+13% +$104K 0.36% 62
2019
Q4 		$771K Sell
11,863
-3,488
-23% -$227K 0.22% 98
2019
Q3 		$1.08M Buy
+15,351
New +$1M 0.43% 56

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Personal CFO Solutions's GILD Position: Q1 2026 in Review

Personal CFO Solutions increased its Gilead Sciences (GILD) stake by 3.2% in Q1 2026, buying an estimated $20.4K and bringing the position to 4,718 shares worth $657K. The position accounts for 0.09% of the portfolio, ranked #202.

Personal CFO Solutions first reported a position in GILD in Q3 2019 and has held it in 24 quarters since. The position peaked at $1.08M in Q3 2019. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Personal CFO Solutions held 4,718 shares of Gilead Sciences worth $657K as of Q1 2026.
  • Personal CFO Solutions bought 146 Gilead Sciences shares in Q1 2026, an estimated $20.4K.
  • Gilead Sciences made up 0.09% of Personal CFO Solutions's portfolio in Q1 2026, its #202 holding.
  • Personal CFO Solutions first reported a position in Gilead Sciences in Q3 2019 and has held it in 24 quarters since.
  • Personal CFO Solutions's Gilead Sciences position peaked at $1.08M in Q3 2019.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Personal CFO Solutions's 13F filing for Q1 2026, filed 30 Apr 2026.